Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether patients with asthma are better able to
manage and control their symptoms by using one inhaler daily that both prevents as well as
treats the symptoms of an asthma exacerbation.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Anti-Asthmatic Agents Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate